Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-044.html
notice number: not-ca-20-044key dates release date: april 09, 2020 first available due date: may 25, 2020 expiration date: may 08, 2023pa-19-052pa-19-053pa-19-054pa-19-056par-19-113par-19-251par-19-252par-19-264rfa-ca-20-005par-20-052par-20-053par-20-077issued by national cancer institute (nci)purposethe purpose of this notice of special interest (nosi) is to: (1) encourage investigators to apply single-cell proteomics for interrogation of premalignant and early malignant lesions; (2) develop new multiparametric biomarkers for cancer screening, early detection and risk assessment; and, (3) establish a biomarkers workflow for a wide coverage of disease variability and individuals at the population level.backgroundrecent advances in single-cell genomic and transcriptomic technologies enabled a better understanding of the cellular content of tumorigenic lesions, including early detection of clonal evolution, detection of the emergence of drug-resistant cells and improved phenotypic characterization of the lesionâ€™s cellular heterogeneity. single-cell mass spectroscopy-based proteomics and antibody-based targeted proteomics are emerging as powerful complementary approaches for the characterization of individual cell types within a lesion, their intercellular networks, and their dynamic physiological state. in addition, these approaches can be used to identify, map and visualize aberrant subcellular structures, intracellular networks, molecular interactomes, and proteoforms some with cancer-associated posttranslational modifications that cannot be predicted by genomic/transcriptomic analysis. the detected molecular, structural and functional aberrations are potential cancer markers and targets for prevention and therapy.research topics that are relevant to this nosi include, but are not limited to:application and submission informationthis notice applies to due dates on or after may 25, 2020 and subsequent receipt dates through may 8, 2023.submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcements through the expiration date of this notice:* note: investigators planning to submit an application in response to this nosi are strongly encouraged to contact and discuss their proposed research/aims with nci program directors of the parent award before writing and submitting their applications to allow for the determination of appropriateness and interest of the nci in any related proposed research.all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:although nci is not listed as a participating organization in all the foas listed above, applications for this initiative will be accepted.inquiriesscientific/research contact(s)jacob kagan, m.sc., ph.d. national cancer institute (nci) telephone: 240-276-7027 email: kaganj@nih.govrichard mazurchuk, ph.d. national cancer institute (nci) telephone: 240-276-7126 email: mazurchukrv@mail.nih.govsudhir srivastava, ph.d., mph national cancer institute (nci) telephone: 240-276-7028 email: srivasts@mail.nih.govsharmistha ghosh-janjigian, ph.d. division of cancer prevention, nci telephone: 240-276-7122 email: sharmistha.ghosh-janjigian@nih.gov weekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.